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Binding of Primitive Hematopoietic Progenitor Cells to Marrow Stromal Cells Involves Heparan Sulfate
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Blast colony-forming cells (BI-CFC) and precolony-forming unit-granulocyte, monocyte (CFU-GM) in human bone marrow bind t o marrow-derived stromal layers grown in the presence of methylprednisolone (MP+), but do not bind t o stroma grown without MP (MP-). The BI-CFC bind t o stroma and form colonies when overlaid with agar; the pre-CFU-GM bind t o stroma and release CFU-GM into the supernatant culture medium (A assay). These two classes of progenitor may represent similar stages of hematopoietic cell development. Their binding t o stroma depends on the presence of heparan sulfate proteoglycan (HS-PG) in the extracellular matrix secreted by the stromal cells. Here, we have analyzed the functional and biochemical properties of HS-PG isolated from MP+ and MP-stromal cultures. HS-PG or isolated HS glycosaminoglycan (GAG) side chains partially blocked progenitor cell binding when they were added t o the 2-hour binding phase of the BI-CFC or A assays. Gel electrophoresis
HE REGULATION of hematopoiesis involves a com-
T plex interplay between the action of hematopoietic growth factors and influences mediated by the cellular microenvironment of the hematopoietic tissues. The restriction of early hematopoietic cell development to hematopoietic tissue is thought to involve the expression of cell adhesion molecules (CAMs) that anchor stem cells and progenitor cells to ligands in the appropriate microenvironment.lJ These or similar CAMs are probably also important for stem cell "homing" following bone marrow transplantation,'J and loss of CAM function is likely to be an important aspect of the pathogenesis of l e~k e m i a .~.~ Bone marrow stromal layers cultured in vitro have been widely used as a model of the hematopoietic microenvironment. In the long-term bone marrow culture they sustain the long-term survival and proliferation of hematopoietic stem cells? They have also been shown to bind a variety of early hematopoietic progenitor cells. We have demonstrated binding by a population of blast colonyforming cells (BI-CFC)6*7 and pre-colony-forming unitgranulocyte, monocyte (CFU-GM),s but not by CFU-GM, burst-forming unit-erythroid (BFU-E), or CFU-granulocyte, erythroid, monocyte, megakaryocyte (CFU-GEMM).9 Others have shown binding by long-term culture-initiating cells (LTCIC)l0 and murine marrow repopulating cells."J2 Thus, binding to stroma is a property shared by a spectrum of HS-PG resolved more bands in matrix preparations from MP+ cultures than in preparations from MP-cultures. The blocking activity of the eluted MP+ HS-PG bands depended partly on the amount of GAG attached t o the protein core and presumably partly on the structure of the core itself. Time course studies demonstrated that the HS-dependent phase of the binding interaction was limited t o the first 30 t o 60 minutes of the 2-hour binding phase. The different blocking effects of MP+ and MP-HS indicate that they have different biochemical properties. The HS-GAG in MP+ stroma has a higher degree of sulfation and a greater negative charge t o mass ratio compared with MP-HS-GAG. Variations in HS may determine specific binding by hematopoietic progenitor cells and a heparan sulfate receptor is envisaged as acting in concert with further cell adhesion molecules (CAMs) on the progenitor cell surface.
o 1992 by The American Society of Hematology.
of early hematopoietic cells, but, in vitro, it is not demonstrated by the majority of committed progenitor cells.
In our experience, BI-CFC and pre-CFU-GM will bind only to adult bone marrow-derived stromal layers grown in the presence of methylprednisolone (MP).6,7 They do not bind to stroma grown from fetal hematopoietic tissue,13 transformed stromal cell lines, or fetal skin fibroblasts (unpublished observations). Previous studied4 have indicated a role for heparan sulfate (HS) in the binding interactions. HS is a member of the glycosaminoglycan (GAG) family of molecules, which are covalently attached to a protein core to form proteoglycan (PG) with one or several GAG chains per molecule. GAGS are important components of the extracellular matrix and have been shown to be important in the regulation of hematopoiesis. They have been implicated in binding and directing the locations of hematopoietic cells and growth factors in the hematopoietic microenvir~nment.~,'~-~~ The basic structure of HS consists of a disaccharide repeat unit (glucuronic acid and N-acetylglucosamine), which can be variously modified by N-sulfation, epimerization of glucuronic to iduronic acid, and 0-sulfation at several different sites. As a result, HS can present an extremely variable structure, which makes it a strong candidate for determining the specificity of recognition and binding sites. Also, Morris et all9 have been able to demonstrate differences between HS extracted from stroma grown with MP and stroma grown without MP. In this study, we have extended the preliminary information concerning the role of HS in progenitor cell binding to the hematopoietic microenvironment in vitro.
MATERIALS AND METHODS

Cells for Culture
Bone marrow cells were obtained, with informed consent, from adult donors of marrow for allogeneic transplantation. Mononuclear cells were separated using Lymphoprep (Nyegaard, Oslo, Norway) according to the manufacturer's recommendations. Nonplastic-adherent cells were prepared by incubating 1 X lo6 mononuclear cells per milliliter, suspended in a-medium (GIBCO, 
Culture Methods
concentrated, and buffer exchange into distilled water or u-medium was done using a Centriprep (Amicon, Stonehouse, UK) with a 10,000 molecular weight cutoff.
The amounts of HS-PG extracted, and other extracts (see below), are given as the starting volume of stroma-conditioned Stromal cultures. Cultured stromal layers were used as feeder layers in the blast colony (BI-CFC) assay (see below) and as a source of HS for analysis and functional experiments. Mononuclear cells were cultured at a concentration of 5 x l@/mL in a-medium supplemented with 10% fetal calf serum, 10% horse serum (GIBCO), and 2 x mol/L MP (Upjohn, Crawley, UK). Where appropriate, stroma was grown without MP and is designated MP-. Stroma grown with MP is designated MP+. The stromal cultures for use as BI-CFC feeder layers were grown in 0.5 mL of medium plus supplements in each well of four-well plates and those for extraction of HS were grown in 80-cm2 tissue culture flasks. All stromal cultures were incubated at 37°C in humidified 5% C02 in air and were fed weekly by total replacement of medium and supplements until they were confluent. This treatment results in exhaustion of endogenous hematopoiesis as determined by CFU-GM assays of trypsinized stroma and the absence of BI-CFC colony formation (see below) on stroma to which no further cells had been added.
Some of the confluent stromal cultures were metabolically labeled with either 50 pCi/mL 35S-sulphate (Amersham, Aylesbury, U K 25 to 40 Ci/mg sulphur) or with 50 FCi/mL 35S-su1-phur + 20 pCi/mL 3H-glucosamine (Amersham; 20 to 40 Ci/ mmoL) for 72 hours.
BI-CFC assay. Non-plastic-adherent cells from 2.5 x lo5 mononuclear cells were added to each well, with four to eight replicates per experimental point. The cells were incubated with the stroma for 2 hours. The stroma was then washed thoroughly with Hanks' Balanced Salt Solution (GIBCO) to remove any nonattached cells and overlaid with 0.370 agar in a-medium plus 15% fetal calf serum. Colonies were counted after 5 to 7 days.6~~
Non-plastic-adherent cells were cocultured for 2 hours with confluent stroma, as described above for the BI-CFC assay. Instead of adding agar, the stroma and adherent hematopoietic cells were overlaid with 0.5 mL of medium plus serum. After 5 days, the nonadherent cells from four wells were pooled, washed, suspended in 0.3% agar in a-medium containing 15% fetal calf serum and 10% 5637 conditioned medium as a source of hematopoietic growth and plated in four 35-mm petri dishes. The cultures were incubated at 37°C for 14 days in humidified 5% C02 in air and granulocyte-macrophage colonies consisting of 50 or more cells were scored. Hence, this assay measures the production of CFU-GM by the stroma-adherent fraction of 1 x 106 mononuclear cells.
Preparations of HS were tested for their ability to block binding during the adhesion phases of the BI-CFC and A assays. For this, HS was added to the stroma at the same time as the non-plastic-adherent mononuclear cells and washed out when the stroma was washed to remove the non-stroma-adherent cells.
Delta (A) assay.
Blocking activity of HS.
Extraction of HS From Stroma
A known volume of culture supernatant was treated with 0.1 U/mL chondroitinase ABC for 12 hours at 37°C to degrade chondroitin sulfate. Samples of 50 mL were applied to diethyl aminoethyl (DEAE) ion exchange columns equilibrated with 20 mmol/L phosphate buffer, pH 6.8, which were then step-eluted first with the same buffer containing 0.35 mol/L salt to remove proteins and hyaluronic acid, and second with buffer containing 1.5 mol/L salt to remove PGs. The resulting HS-PG was
Preparation of HS-PG.
medium because of the difficulties involved in accurate measurement of the small amounts obtained.
The HS-PG fraction was concentrated to a volume of 5 mL in distilled water and, in some experiments, treated with 2 mg/mL pronase in 10 mmol/L Tris buffer, pH 7.8, for 16 hours at 37°C to degrade core protein and other contaminants. The sample was then incubated with an equal volume of 2 mol/L sodium borohydride in 100 mmol/L sodium hydroxide to cleave the HS-GAG chains from the protein core. The mixture was neutralized by dropwise addition of acetic acid. HS-GAG chains were separated from protein by ion exchange chromatography, step-eluting with 0.35 mol/L salt to remove protein and 1.5 mol/L salt to remove HS-GAG. The HS-GAG was concentrated, and buffer was exchanged using a Centriprep (Amicon). The presence of GAG was confirmed by spotting an aliquot onto nitrocellulose and staining with 0.25% alcian blue for 5 minutes. The absence of any detectable contaminating protein was confirmed by resolving the material on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transfer to nitrocellulose, and staining for protein with AuroDye forte and silver enhancement (Amersham).
Preparation of HS core proteins. Purified HS-PGs were treated with 2.0 U/mL heparanase I1 (Sigma, Poole, UK) for 14 hours at 37°C and the reaction was terminated with 500 Fg heparin (Sigma). In some cases, samples were subjected to gel filtration on Sephadex G25 (Pharmacia, Milton Keynes, UK) to separate small digestion products from the protein cores. Alternatively, samples were subjected to sodium borohydride/sodium hydroxide to cleave the HS-GAG chains from the cores and separated by DEAE anion exchange chromatography, which retains HS-GAG, but not core protein.
Analysis of HS From Stroma
Supernatants from stromal cultures labeled with 35S-sulfate and 3H-glucosamine were analyzed by DEAE ion exchange chromatography. Samples were treated with 0.1 U/mL chondroitinase ABC (Sigma) for 5 hours at 37°C. Aliquots were applied to a column equilibrated with 20 mmol/L phosphate buffer, pH 6.8, containing 0.15 mol/L sodium chloride and 1% Triton X-100, and step-eluted with the same buffer containing 0.35 mol/L sodium chloride (to elute molecules other than sulfated GAGs) and then with buffer containing 1.5 mol/L sodium chloride (to elute sulfated GAGs). 35S and 3H were counted simultaneously on a LKB rack B-liquid scintillation counter (Pharmacia) using Emulsifier Safe (Packard, Groningen, Holland) scintillation fluid. The ratio was corrected for the alteration by steroid of the relative incorporation of glucose and glucosamine for GAG synthesis.
3SS-labeled HS-PG preparations were resolved on a linear 4% to 15% polyacrylamide gradient
The stacking gel consisted of 3.5% acrylamide. The molecular weight markers were 14C-methylated protein standards (Amersham). Gels were fixed in 10% acetic acid and 5% methanol for 1 hour. For fluorography, gels were soaked for 20 minutes in once used dimethyl sulfoxide (DMSO), 20 minutes in fresh DMSO, 3 hours in 22% 2,5-diphenyloxazole (PPO) in DMSO, and 1 hour in distilled water.= They were dried under vacuum for 4 hours with gradual heating to 70°C and exposed to Kodak X-OMAT x-ray film (Eastman Kodak, Rochester, NY) at -70°C.
To electroelute the PGs corresponding to different molecular
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Charge to mass ratio.
Electrophoresis and electroelution of HS.
use only. 
Statistical Analyses
Data were analyzed using the Wilcoxon rank sum test.
RESULTS
Influence of MP+ and MP-HS-GAGS on Binding of BI-CFC and Pre-CFU-GM to MP+ Stromal Layers
Addition of increasing amounts of MP-HS-GAGS to the binding phase of the BI-CFC assay had no significant effect on colony formation at any concentration tested (Fig 1) . Addition of increasing amounts of MP+ HS-GAGS progressively reduced the number of colonies that formed on the stromal layer. Although the inhibition was not significant in the presence of 0.5 or 1.0 equivalent volumes of HS-GAG, it was significant in the presence of 2.0 or 4.0 equivalent volumes (P < .01 and .05, respectively, in two separate experiments). However, at the highest concentration tested (4.0 equivalent volumes), inhibition was incomplete and the curve best fitting the data indicated a plateau in inhibitory effect. The effect of 4.0 equivalent volumes was tested in eight further experiments and, overall, colony formation was reduced to 38% 4 3% (mean 2 SEM) of controlvalues (24% f 14.5%; mean ~f: 1 SD of five experiments of eight wells per point and three experiments of four wells per point). In one experiment, the amount of MP+ HS-GAG was trebled to 12.0 equivalent volumes, but colony formation was not further reduced compared with the effect of 4.0 equivalent volumes. The binding of pre-CFU-GM was also differentially reduced by the presence of 4.0 equivalent volumes of MP+ and MP-HS-GAG during the 2-hour binding phase of the assay (Fig 2) (P < .01 to .05 for both day 7 and day 14 CFU-GM assays). The MP-HS-GAG had no significant effect in this assay. The ability of intact MP+ HS-PG was evaluated in three separate experiments (Fig  3) , which showed that the intact molecule, as well as the GAG side chains, inhibited progenitor cell-binding in the BI-CFC assay (P < .01 to .001 in three experiments).
The different effects of MP+ and MP-HS-GAG did not result from lower levels of synthesis in MP-cultures, which produce, if anything, more than the MP+ cultures as judged by precipitation of 35S-sulfate labeled GAGS with cetyl pyridinium chloride coupled with selective digestion of the different GAGS (Siczkowski et al, in preparation). However, the ratio of 35S-sulfate to 3H-giucosamine incorporation for MP+ HS-GAG was twice that of MP-HS-GAG (Fig 4) , indicating that the material from the steroidtreated stroma had a twofold greater negative charge per unit mass. Neither is MP+ HS-GAG inhibitory to colony formation, since it does not prevent colony formation by CFU-GM, even when it is present for the entire 14-day culture period. The specific effect of MP+ HS-GAG is further indicated by the lack of inhibitory effect of heparin, a highly sulfated structural analogue, even when it was added at a concentration of 500 kg/mL.
Influence of HS-PG Core Proteins on BI-CFC Binding to Stroma
Treatment of MP+ HS-PG with heparanase I1 did not prevent the blocking activity of the HS-PG. However, heparanase treatment does not completely digest HS, because it is cleaved at certain sites, which results in the production of GAG fragments and core protein with "stubs" of GAG remaining attached. The data in Fig 5 also show that the blocking activity was not changed by passing use only. the heparanase-treated material down a G25 column. This produced a preparation containing core protein plus attached stubs plus large HS-GAG fragments. Treatment with borohydride, on the other hand, completely removes the GAG side chains from the core. This, followed by DEAE column chromatography to separate the protein from the GAG, resulted in a pure protein core, but this did not have any blocking activity (Fig 5) .
Influence of Individual HS-PGs on BI-CFC Binding to Stroma
SDS-PAGE of MP+ and MP-HS-PG resolved multiple HS-PG species. Most were present in HS-PGs from both sources, but there were a few additional bands in the material from MP+ cultures (Fig 6A) . Bands corresponding to different molecular weight ranges (Fig 6B) of MP+ HS-PG were elecroeluted and analyzed for the ability to block BI-CFC binding to stroma. The blocking activity of fraction 3 was the greatest (Fig 7 A P < most HS as a percentage of the total HS eluted (Fig 7B) . Fraction 3 was the only fraction that was consistently inhibitory in this series of experiments. Inhibition by fraction 5 was significant in two of three experiments (P < .05 to .01) and inhibition by fraction 4 was significant in one of three experiments (P < .Ol). However, the HS content of the different fractions does not seem to account completely for the level of inhibition exerted by the individual fractions (Fig 7C) , as indicated by the level of correlation between the two values.
Discrimination of Different Binding Phases
The fact that we were unable to obtain total inhibition of binding indicates that more than one CAM participates in the interaction and raises the possibility that HS is not required for the entire 2-hour binding phase of the assay. In these experiments, the addition of MP+ HS-GAG was delayed for up to 90 minutes (so that the total coincubation time was up to 210 minutes, ie, delay +2 hours). The inhibition was significant when the addition was not delayed (P < .001; .Ol), and in one of the experiments where addition was delayed for 30 minutes (P < .001). No significant inhibition was observed at any of the other time points tested (Fig 8) . This result identifies the HS-dependent phase of binding and implicates HS in the specific recognition of stroma by BI-CFC.
DISCUSSION
It is generally accepted that hematopoietic progenitor cells can bind to extracellular matrix molecules that are found in hematopoietic tissue and that these interactions may be responsible for determining the precise location of hematopoietic cells in the hematopoietic microenvironment.1,23-26 These interactions are likely to be distinct from the initial phase of homing of intravenously transfused stem cells to the bone marrow, which involves interaction with the luminal surface of sinus e n d o t h e l i~m .~~.~~ In this study, we have confirmed our observation that HS-PG is a candidate ligand for a receptor on BI-CFC and on pre-CFU-GM. Most of the ability of the PGs to block binding appeared to reside in the GAG side chains, rather than in the protein core, since complete stripping of GAG from the core destroyed the activity, and since purified protein-free GAG retained the activity.
The variability in the structure of HS-GAG makes it an attractive candidate for determining the specificity of binding interactions.?' This view is supported by the current results showing that there is a considerable charge difference between HS-GAG derived from MP+ and MPstroma, which corresponds to their different capacities to block binding in the BI-CFC and A assays. We used HS from the stromal culture medium, because it was not possible to obtain sufficient material from the cell layer, whereas the BI-CFC and pre-CFU-GM bind to molecules on the stromal cell surface or in the extracellular matrix. Morris et al," comparing cell layer and soluble material, have shown that the HS chains from the two sources are of similar size and that oligosaccharide mapping did not show structural differences between the HS in the medium and the HS in the cell layer from the same cultures. HS in the cell layer is located predominantly in the pericellular region. The HS-GAG exists as an extended structure, and a typical 20-Kd chain may project some 40 nmz8 in contrast to globular proteins that project only 5 to 10 nm. This extended conformation may facilitate binding interactions between cells separated by the substantial extracellular matrix layer found in the stromal cultures, especially if the binding molecule on the hematopoietic progenitor cell also exists as an extended structure.zyJ" Morris et ally have shown, using comparable material, that MP+ HS-GAG has a grcatcr ncgative charge than MP-HS-GAG and that structural differences can be discerned by oligosaccharide mapping, but that MP did not influcncc the molecular size of the HS-GAG chains. Furthcrmorc, the requirement for a unique HS-GAG structure is suggested by the failure of heparin and of HS-GAG from bovine kidney to block binding in the BI-CFC assay.lJ The differences between MP+ and MP-HS-GAG are due predominantly to enrichment in MP+ HS-GAG of highly sulfated dissacharidcs.Iy Other interactions have been described that have a strict requirement for spccific sulfate groups. One is the requirement for a glucosamine 3-0-sulfate group, present in only 1% of HS-GAG chains produced by bovine aortic endothelial CCIIS,~' for highaffinity binding by antithrombin. This contrasts with interactions mediated by the neuronal CAM, N-CAM, where adhesion can be inhibited by heparin,'? suggesting that a relatively common disaccharide structurc is involved.
The use of steroid in marrow stromal cultures may induce a distinct pattern of sulfation, with a consequent increase in negative charge density, by inducing or upregulating the activity of enzymes that are responsible for modifications to the basic HS structure. Indeed, there are many tissue specific differences in HS structure? and many different structures are possible. The degree and position of O-sulfation is an important variable in determining the structure and properties of HS-GAG from different sources,.u and may be responsible for conferring uniquely recognizable structures on the heparan backbone. The exact positions of the additional sulfate groups in the HS disaccharides use only. produced by marrow stroma in the presence of steroid remain to be determined, but they also may be rcsponsible for a unique structure that is involved in the adhesion of early hematopoietic progenitor cells.
Our results suggest that the core protein may not play an important role in BI-CFC binding to stroma, beyond that of organizing GAG side chains. Nevertheless, this question cannot be considered resolved, because it requires analysis of individual core proteins and these are difficult to obtain in an absolutely pure form with retention of function. The methods available include enzymatic degradation to remove side chains, but, in the case of HS-degrading enzymes, degradation is not total and stubs of GAG remain attached to the core. Chemical treatments result in complete removal of GAG, but are harsher and their effects on protein structure, and possibly function, are difficult to evaluate. One potential solution to the problem may be to clone the protein cores and obtain recombinant protein by expression in bacteria, but, even here, protein conformation may be influenced by the absence of the GAG.
The demonstration that BI-CFC and prc-CFU-GM bind to HS strongly suggests that they cxprcss a cell surface HS receptor. Little is known about this putative receptor beyond the information obtained in functional studies. As we have shown, it is functionally expressed by BI-CFC and prc-CFU-GM, but not by CFU-GEMM, CFU-GM, or RFU-E, which do not bind to stroma." However, as we have shown by our time course studies, it is not the only cell adhesion mechanism involved in binding BI-CFC to stroma. Other studies have demonstrated that more than one cell adhesion mechanism is expressed by these cells. One is sensitive to treatment with phosphatidylinositol-specific phospholipase C (PI-PLC) and is therefore likely to be attached to the cell membrane by a phosphatidylinositol (PI) anchor. The othcr(s) is sensitive to treatment with trypsin and is more likely to be a transmembrane molecuI~(s).".~~ Thc HS-GAG receptor is probably the cell use only. Our data are consistent with an initial phase of adhesion involving the specific recognition of HS-GAG by a PIanchored cell adhesion component followed by the engagement of further adhesion mechanisms that remain to be identified. Similar models proposed by other investigator^^^,^ suggest that the PG-mediated component of progenitor binding is responsible for strengthening the bond, rather than for initial specific intermolecular recognition. It will be necessary to perform studies in closely comparable systems before these differences can be resolved, because, overall, hematopoietic stem and progenitor cells are involved in a wide variety of multimolecular binding interactions.35 30 
